Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Penas

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Pituitary|April 24, 2016
Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinomaCarlos Kamiya-Matsuoka, David Cachia, Steven G Waguespack, et al.
Journal of Neuro-Oncology|October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastomaMark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Neuro-Oncology Advances|October 25, 2021
Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastomaShiao-Pei Weathers, Julie Rood-Breithaupt, John de Groot, et al.
Journal of Neurology|January 22, 2015
PET-Florbetapir findings in primary cerebral amyloidomaAlberto Villarejo-Galende, Pilar Sarandeses, Marta Penas-Prado, et al.
European Journal of Endocrinology|July 27, 2019
Treatment and long-term outcomes in pituitary carcinoma: a cohort studyFernando Santos-Pinheiro, Marta Penas-Prado, Carlos Kamiya-Matsuoka, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II studyNazanin Majd, Steven G Waguespack, Filip Janku, et al.
Cancer Genetics|February 27, 2019
RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case reportNazanin K Majd, Nicolas R Metrus, Fernando Santos-Pinheiro, et al.
Journal of the Neurological Sciences|May 31, 2022
Malignant melanocytic schwannian tumor and leptomeningeal disease: A case series with a focus on managementRachel Woodford, Lyndsey Prather, Cassandra Helfer, et al.
CNS Oncology|February 10, 2022
Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology BranchOrwa Aboud, Ritu Shah, Elizabeth Vera, et al.
Journal of Neuro-Oncology|June 6, 2018
Rethinking medulloblastoma from a targeted therapeutics perspectiveYuuri Hashimoto, Marta Penas-Prado, Shouhao Zhou, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Pituitary|April 24, 2016
Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinomaCarlos Kamiya-Matsuoka, David Cachia, Steven G Waguespack, et al.
Journal of Neuro-Oncology|October 23, 2016
NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastomaMark R Gilbert, Stephanie L Pugh, Ken Aldape, et al.
Neuro-Oncology Advances|October 25, 2021
Results of a phase I trial to assess the safety of macitentan in combination with temozolomide for the treatment of recurrent glioblastomaShiao-Pei Weathers, Julie Rood-Breithaupt, John de Groot, et al.
Journal of Neurology|January 22, 2015
PET-Florbetapir findings in primary cerebral amyloidomaAlberto Villarejo-Galende, Pilar Sarandeses, Marta Penas-Prado, et al.
European Journal of Endocrinology|July 27, 2019
Treatment and long-term outcomes in pituitary carcinoma: a cohort studyFernando Santos-Pinheiro, Marta Penas-Prado, Carlos Kamiya-Matsuoka, et al.
Journal for Immunotherapy of Cancer|January 11, 2021
Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II studyNazanin Majd, Steven G Waguespack, Filip Janku, et al.
Cancer Genetics|February 27, 2019
RBM10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: A case reportNazanin K Majd, Nicolas R Metrus, Fernando Santos-Pinheiro, et al.
Journal of the Neurological Sciences|May 31, 2022
Malignant melanocytic schwannian tumor and leptomeningeal disease: A case series with a focus on managementRachel Woodford, Lyndsey Prather, Cassandra Helfer, et al.
CNS Oncology|February 10, 2022
Challenges of imaging interpretation to predict oligodendroglioma grade: a report from the Neuro-Oncology BranchOrwa Aboud, Ritu Shah, Elizabeth Vera, et al.
Journal of Neuro-Oncology|June 6, 2018
Rethinking medulloblastoma from a targeted therapeutics perspectiveYuuri Hashimoto, Marta Penas-Prado, Shouhao Zhou, et al.
Pageof 11